EP3464265
Fjölbrigði af N-[(3-flúor-4-metoxýpýridín-2-ýl)metýl]-3-(metoxýmetýl)-1-({4-[(2-oxópýridín-1-ýl)metýl]fenýl}metýl)pýrasól-4-karboxamíði sem kallikrein-hindrar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.6.2017EP published:
13.7.2022EP application number:
17728614.3
EP translation filed:
15.8.2022Grant published:
15.9.2022EPO information:
European Patent Register
Max expiry date:
31.5.2037Expiry date:
31.5.2026Next due date:
30.6.2026
Title in English:
POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AS KALLIKREIN INHIBITORSLanguage of the patent:
English
Timeline
Today
1.6.2017EP application
13.7.2022EP Publication
15.8.2022Translation submitted
15.9.2022Registration published
31.5.2026Expires
Owner
Name:
Kalvista Pharmaceuticals LimitedAddress:
Porton Science Park Bybrook Road, Porton Down Wiltshire SP4 0BF, GB
Inventor
Name:
BEATON, HaydnAddress:
Quorn Loughborough LE12 8PF, GB
Name:
CROWE, David MalcolmAddress:
Reading RG2 0NH, GB
Name:
EDWARDS, Hannah JoyAddress:
Porton Down Salisbury SP4 0JQ, GB
Name:
GRIFFITHS-HAYNES, Nicholas JamesAddress:
Warwickshire CV23 0QG, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201609607Date:
1.6.2016Country:
GB
Number:
201662344059 PDate:
1.6.2016Country:
US
Classification
Categories:
C07D 401/10, A61K 31/4439, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 24.5.2023
Expires: 31.5.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 7.5.2024
Expires: 31.5.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 16.5.2025
Expires: 31.5.2026
Payer: Árnason Faktor ehf.